You can install PPMD to make it easier to access on your device. A network connection is still required to view medication and interaction information.
You should now see a icon on your home screen.
Tap then menu button, and then tap Install.
Not all web browsers and platforms support progressive web applications (PWA). Consult the documentation for your web browser for additional assistance.
N/A
This was an open label, single and multiple dose four cohort study in 98 healthy volunteers. Participants were administered a single dose of GS-9857 100 mg alone or in combination with inhibitors or inducers of drug transporters or CYP isoenzymes. These drugs included rifampin 600 mg x 1 dose fasted, or rifampin 600 mg daily for seven days fed. Geometric means ratios and 90% Confidence Intervals for GS-9857 were estimated and compared to pre-specified lack of PK alteration boundaries 70% - 143%. Safety was assessed by routine laboratory and clinical monitoring. Five subjects discontinued the study drug during the study period.
Study data were not given, but the authors concluded that inhibition of intestinal OATP by grapefruit juice on GS-9857 had limited effect when administered with food.
Kirby BJ, J Taylor, Stamm LM, Q Song, Y Li, A Mathias. Evaluation of pan genotypic hcv ns3/4a protease inhibitor gs-9857 as the object of transporter and cytochrome p450 mediated drug-drug interactions. 17th International Workshop On Clinical Pharmacology Of Hiv And Hepatitis Therapy. Washington, DC, USA. ; 2016.